Key Record Dates
ClinicalTrials.gov Identifier: | NCT02504372 |
---|---|
Brief Title: | Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) (PEARLS) |
First Submitted : | July 20, 2015 |
First Submitted that Met QC Criteria : | July 20, 2015 |
First Posted : | July 21, 2015 (Estimate) |
Results First Submitted : | January 9, 2024 |
Results First Submitted that Met QC Criteria : | February 13, 2024 |
Results First Posted : | February 15, 2024 |
Last Update Submitted that Met QC Criteria : | February 13, 2024 |
Last Update Posted : | February 15, 2024 |